209 related articles for article (PubMed ID: 6753513)
21. [Current status and outlook of biological therapies in mental diseases].
Predescu V; Alexandrescu L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):241-52. PubMed ID: 2882589
[No Abstract] [Full Text] [Related]
22. The management of depression.
Lader M
Trans Med Soc Lond; 1975-1977; 92-93():22-7. PubMed ID: 1053121
[No Abstract] [Full Text] [Related]
23. Peripheral alpha-adrenergic activity in the affective disorders.
Wood K; Coppen A
Adv Biochem Psychopharmacol; 1982; 32():13-9. PubMed ID: 6283806
[No Abstract] [Full Text] [Related]
24. The overnight dexamethasone suppression test: clinical and theoretical review.
Gwirtsman H; Gerner RH; Sternbach H
J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505
[TBL] [Abstract][Full Text] [Related]
25. Neurotransmitter precursor therapies in affective disorders.
von Lerber-Good WF
Int J Vitam Nutr Res Suppl; 1986; 29():69-82. PubMed ID: 2871118
[No Abstract] [Full Text] [Related]
26. Mood drugs.
Baldessarini RJ
Dis Mon; 1977 Nov; 24(2):1-65. PubMed ID: 21061
[No Abstract] [Full Text] [Related]
27. Pergolide: an antidepressant adjuvant for mood disorders?
Bouckoms A; Mangini L
Psychopharmacol Bull; 1993; 29(2):207-11. PubMed ID: 8290667
[TBL] [Abstract][Full Text] [Related]
28. The practical management of affective disorders.
Shaw DM
Br J Psychiatry; 1977 May; 130():432-51. PubMed ID: 16679
[No Abstract] [Full Text] [Related]
29. Biology of manic-melancholic disorders.
Rafaelsen OJ
Med J Aust; 1980 Jun; 1(13):637-43. PubMed ID: 7421618
[No Abstract] [Full Text] [Related]
30. 5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs.
Herman ZS
Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):25-43. PubMed ID: 128747
[No Abstract] [Full Text] [Related]
31. [The obsessive-compulsive disorder. Pharmacotherapeutic and neurobiological aspects and the relation to affective pathology].
Fornaro P
Minerva Psichiatr; 1988; 29(2):95-103. PubMed ID: 3057306
[No Abstract] [Full Text] [Related]
32. Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
Grahame-Smith DG; Green AR
Br J Pharmacol; 1974 Mar; 50(3):443P-446P. PubMed ID: 4277620
[No Abstract] [Full Text] [Related]
33. Neurochemical and neuropharmacological aspects of depression.
Leonard BE
Int Rev Neurobiol; 1975; 18():357-87. PubMed ID: 1354
[No Abstract] [Full Text] [Related]
34. Perspectives and practical applications in psychopharmacogenetics.
Mendlewicz J
Prog Neuropsychopharmacol; 1979; 3(1-3):155-63. PubMed ID: 401337
[TBL] [Abstract][Full Text] [Related]
35. The biology of affective disorders.
Sachar EJ; Baron M
Annu Rev Neurosci; 1979; 2():505-17. PubMed ID: 231927
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
Dilsaver SC
J Clin Psychopharmacol; 1986 Apr; 6(2):65-74. PubMed ID: 3517080
[TBL] [Abstract][Full Text] [Related]
37. Depression as seen by the psychiatrist.
Cooper AM; Shamoian CA
Dis Mon; 1979 Sep; 25(12):1-64. PubMed ID: 114379
[No Abstract] [Full Text] [Related]
38. Migraine treatment and its biological implications.
Sandler M
Panminerva Med; 1982; 24(1):73-6. PubMed ID: 6755361
[No Abstract] [Full Text] [Related]
39. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Reeves RR; Nixon FE
South Med J; 1995 Feb; 88(2):248-9; author reply 250. PubMed ID: 7839178
[No Abstract] [Full Text] [Related]
40. [Characteristic features of anesthesia in patients with concomitant neuropsychiatric diseases].
Beliakov VA
Anesteziol Reanimatol; 1983; (3):72-7. PubMed ID: 6351672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
